Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Licorisoflavan A shows weak scavenging activity against superoxide anion radical, it and licoricidin have potential for the development of novel host-modulating strategies for the treatment of cytokine and/or MMP-mediated disorders such as periodontitis.Licorisoflavan A has bactericidal effects on S. mutans UA159 at the concentration of ≥4 g/ml, it can be useful in developing oral hygiene products, such as gargling solutions and dentifrices for preventing dental caries.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 620.00 | |
1 mL * 10 mM (in DMSO) | Inquiry | $ 630.00 |
Description | Licorisoflavan A shows weak scavenging activity against superoxide anion radical, it and licoricidin have potential for the development of novel host-modulating strategies for the treatment of cytokine and/or MMP-mediated disorders such as periodontitis.Licorisoflavan A has bactericidal effects on S. mutans UA159 at the concentration of ≥4 g/ml, it can be useful in developing oral hygiene products, such as gargling solutions and dentifrices for preventing dental caries. |
Source |
Molecular Weight | 438.56 |
Formula | C27H34O5 |
CAS No. | 129314-37-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Licorisoflavan A 129314-37-0 Cell Cycle/Checkpoint DNA Damage/DNA Repair Immunology/Inflammation NF-Κb Proteases/Proteasome DNA/RNA Synthesis MMP IL Receptor NF-κB inhibitor inhibit